nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Open-label, Crossover Study Comparing EPA+DPA-Free Fatty Acids and EPA-Ethyl Esters in Adults with Elevated Triglycerides: ENHANCE-IT
|
Maki, Kevin C. |
|
|
16 |
1S |
p. e14 |
artikel |
2 |
Association of Cholesterol Efflux Capacity with Adverse Cardiovascular Outcomes: A Meta-Analysis†
|
Lee, Jane J. |
|
|
16 |
1S |
p. e1-e2 |
artikel |
3 |
Atherosclerosis- Preventing CVD by Increasing Awareness Regarding Risk Factors
|
Jiva, Erum Sohail |
|
|
16 |
1S |
p. e32-e34 |
artikel |
4 |
Case Series: Patients with Hypo-Responsiveness to PCSK9 Inhibitor Therapy
|
Pulipati, Vishnu Priya |
|
|
16 |
1S |
p. e29-e30 |
artikel |
5 |
Case Study of Hypertriglyceridemia from COVID-19 Pfizer-BioNTech Vaccination in a Patient with Familial Hypercholesteremia
|
Cheung, Brian |
|
|
16 |
1S |
p. e13-e14 |
artikel |
6 |
Characterization of Patients with LDL-Cholesterol ≥ 190mg/dL in a Tertiary Care Center
|
Mezick, Hayden McCord |
|
|
16 |
1S |
p. e21-e22 |
artikel |
7 |
Cholesteryl Ester Storage Disease Uncovered During Unusually Broad Genetic Screening for Hypercholesterolemia
|
Sakers, Alexander |
|
|
16 |
1S |
p. e16-e17 |
artikel |
8 |
Circulating Levels of PCSK9, ANGPTL3 and Lp(a) in Stage III Breast Cancers
|
Chong, Émilie Wong |
|
|
16 |
1S |
p. e3-e4 |
artikel |
9 |
Clinical and Economic Impact of Early Rreatment Initiation with Evolocumab in Patients with a Recent Myocardial Infarction in the United States
|
Martinez, Laura |
|
|
16 |
1S |
p. e17-e18 |
artikel |
10 |
Clinical Characteristics of Atherosclerotic Cardiovascular Disease Patients and Familial Hypercholesterolemia Patients: A Database Analysis in the US. †
|
Seshagiri, Divyagiri |
|
|
16 |
1S |
p. e9-e10 |
artikel |
11 |
Comparison of the Four Major US Guidelines for Lipid Lowering Therapy for the Primary Prevention of ASCVD in Patients with Diabetes
|
Karalis, Dean G. |
|
|
16 |
1S |
p. e4-e5 |
artikel |
12 |
Disparities Among Gender and Racial Groups in the Achievement of Optimal Lipid Levels in Patients Following Acute Coronary Syndrome
|
Ambrosino, Maxwell |
|
|
16 |
1S |
p. e15-e16 |
artikel |
13 |
Dysbetalipoproteinamia: Implications for Pre-Conception, Pregnancy and Beyond
|
Raj, Suchitra |
|
|
16 |
1S |
p. e21 |
artikel |
14 |
Early and Late Recurrent Cardiovascular Risk in Patients With Recent Acute Coronary Syndrome: Meta-Analysis and Implications in Trial Design†
|
Chi, Gerald |
|
|
16 |
1S |
p. e8 |
artikel |
15 |
Eicosapentaenoic Acid Increases Vascular and Pulmonary Endothelial Ferritin Levels with Enhanced Heme Oxygenase-1 Expression during Inflammation
|
Mason, R. Preston |
|
|
16 |
1S |
p. e28 |
artikel |
16 |
Elevated Lipoprotein(a) Attenuates the Effect of Statin Therapy on Atherogenic Lipoproteins in Patients with Familial Hypercholesterolemia
|
Maimo, Willibroad |
|
|
16 |
1S |
p. e2 |
artikel |
17 |
Evaluation of the Real-World Effectiveness and Safety of Lomitapide in the Management of HoFH: The European Experience Study
|
D'Erasmo, Laura |
|
|
16 |
1S |
p. e19-e20 |
artikel |
18 |
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice
|
Basu, Debapriya |
|
|
16 |
1S |
p. e29 |
artikel |
19 |
Evinacumab Markedly Reduces Low-density Lipoprotein Cholesterol in Adolescent Patients With Homozygous Familial Hypercholesterolemia†
|
Reeskamp, Laurens |
|
|
16 |
1S |
p. e19 |
artikel |
20 |
Familial Hypercholesterolemia Due to APOE p.Leu167del Mutation, Response to Bempedoic Acid/Ezetimibe, after Failure of Both Inclisiran and Evolocumab, in a Statin Intolerant Patient: A Case Report
|
Doyle, Michael S. |
|
|
16 |
1S |
p. e30-e31 |
artikel |
21 |
Genetic Testing in Patients with High Lipoprotein(a): Experience from the UCSD Lipoprotein(a) Specialty Clinic†
|
Epstein, Elizabeth S. |
|
|
16 |
1S |
p. e12-e13 |
artikel |
22 |
Lomitapide Effectively Reduces Triglyceride (TG) Levels in Familial Chylomicronemia Syndrome (FCS)
|
Cefalu, Angelo |
|
|
16 |
1S |
p. e17 |
artikel |
23 |
Lomitapide Reduces LDL-C and Favourably Affects Carotid Intima Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting
|
Blom, Dirk |
|
|
16 |
1S |
p. e18-e19 |
artikel |
24 |
Meta-Analysis of 19 Clinical Trials using Omega-3 Fatty Acids Indicate Distinct Outcomes for Icosapent Ethyl
|
Liakou, Polyxeni |
|
|
16 |
1S |
p. e28 |
artikel |
25 |
Moderate Alcohol Consumption and Lipoprotein Subfractions: A Systematic Review of Intervention and Observational Studies
|
Wilkens, Trine |
|
|
16 |
1S |
p. e27 |
artikel |
26 |
New Targeted Therapies for Improving Cholesterol and CV Outcomes in Patients with Familial Hypercholesterolemia
|
Hanson, Brianna |
|
|
16 |
1S |
p. e23-e24 |
artikel |
27 |
Novel NGS-Based Estimation of Kringle-IV-2 Repeats of LPA Gene Improves Genetic Identification of Elevated Lp(a) Levels
|
Roth, Mendel |
|
|
16 |
1S |
p. e11-e12 |
artikel |
28 |
Ordering Trends and Report Outcomes for Lipid Genes on a Comprehensive Cardiovascular Genetics Menu
|
Towne, Meghan |
|
|
16 |
1S |
p. e10-e11 |
artikel |
29 |
Performance of Different LDL-C Equations in an Intervention Improving Atherogenic Dyslipidemia in Participants with Type 2 Diabetes
|
Athinarayanan, Shaminie J |
|
|
16 |
1S |
p. e5-e6 |
artikel |
30 |
Phytosterol Therapy Effectively Reduces LDL-C in Middle-Aged, Borderline Risk South Asians
|
Dash, Rajesh |
|
|
16 |
1S |
p. e25 |
artikel |
31 |
Provider Feedback on Implementation of a Genomic Clinical Decision Support for Familial Hypercholesterolemia
|
Bangash, Hana |
|
|
16 |
1S |
p. e24-e25 |
artikel |
32 |
Quantifying the Contribution of Lipoprotein (a) to Atherogenic Lipoprotein Burden: A Novel Particle-Based Approach
|
Chilazi, Michael |
|
|
16 |
1S |
p. e3 |
artikel |
33 |
Recurrent Hypertriglyceridemia-Associated Pancreatitis in a Pregnant Woman Complicated by Severe Socioeconomic Insecurity
|
Sakers, Alexander |
|
|
16 |
1S |
p. e14-e15 |
artikel |
34 |
RNA Studies Demonstrate that the LDLR c.2389+4A>G Intronic Variant Causes Familial Hypercholesterolemia through an RNA Splicing Impact
|
Zimmermann, Heather |
|
|
16 |
1S |
p. e10 |
artikel |
35 |
Safety and Efficacy of Bempedoic Acid in Statin-Intolerant Patients
|
Buda, Kevin |
|
|
16 |
1S |
p. e26 |
artikel |
36 |
Screening for Familial Hypercholesterolemia using Epic Secure Chat in Comparison to Epic Letter as Educational Outreach˄
|
Alam, Loba |
|
|
16 |
1S |
p. e20-e21 |
artikel |
37 |
Spotlight on Abetalipoproteinemia and Related Hypobetalipoproteinemia Disorders: A Simplified Nomenclature and Clinical Guidelines. †
|
Bredefeld, Cindy Lee |
|
|
16 |
1S |
p. e22-e23 |
artikel |
38 |
Time-Averaged LDL-C Lowering with Evolocumab: Pooled Analysis of Phase 2 Trials
|
Schludi, Belinda |
|
|
16 |
1S |
p. e31 |
artikel |
39 |
Treatment Patterns in Atherosclerotic Cardiovascular Disease Patients and Familial Hypercholesterolemia Patients: A Database Cohort Study in the US†
|
Lahoz, Rachel |
|
|
16 |
1S |
p. e6-e7 |
artikel |
40 |
Use of Guideline Directed Lipid Lowering Therapy among Patients with Diabetes without ASCVD in a Large Cardiology Practice
|
Karalis, Dean G. |
|
|
16 |
1S |
p. e4 |
artikel |
41 |
Utilization of High Intensity Statins in Patients Hospitalized for Myocardial Infarction
|
Alabre-Bonsu, Alisha Frances |
|
|
16 |
1S |
p. e7-e8 |
artikel |